BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2019 9:57:12 AM | Browse: 1146 | Download: 2633
 |
Received |
|
2018-11-05 02:52 |
|
Peer-Review Started |
|
2018-11-05 09:29 |
|
First Decision by Editorial Office Director |
|
2018-12-28 17:37 |
|
Return for Revision |
|
2018-12-29 02:20 |
|
Revised |
|
2019-01-11 15:17 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-01-18 11:26 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-01-18 23:03 |
|
Articles in Press |
|
2019-01-18 23:03 |
|
Edit the Manuscript by Language Editor |
|
2019-01-24 08:40 |
|
Typeset the Manuscript |
|
2019-02-13 09:41 |
|
Publish the Manuscript Online |
|
2019-02-14 09:57 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hao Luo, Xia-Xia Zhang, Li-Hua Cao, Ning Tan, Qian Kang, Hong-Li Xi, Min Yu and Xiao-Yuan Xu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the 13th Five-Year Plan |
2018ZX09206005-002 |
|
| Corresponding Author |
Xiao-Yuan Xu, MD, Professor, Department of Infectious Diseases, Peking University First Hospital, Xishiku Street 8, Beijing 100034, China. xiaoyuanxu6@163.com |
| Key Words |
Chronic hepatitis B; Hepatitis B virus RNA; Virological response; HBeAg seroconversion; Entecavir |
| Core Tip |
HBeAg seroconversion was more likely to be achieved for chronic hepatitis B patients with hepatitis B virus (HBV) RNA levels below 4.12 log10 copies/mL before treatment. In the partial virological response group, serum HBV RNA showed an increasing trend. |
| Publish Date |
2019-02-14 09:57 |
| Citation |
Luo H, Zhang XX, Cao LH, Tan N, Kang Q, Xi HL, Yu M, Xu XY. Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients. World J Gastroenterol 2019; 25(6): 719-728 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i6/719.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i6.719 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
